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Abstract
Background Durability of protection and long-term quality
of life (QoL) are critical outcome parameters of abdominal
aortic aneurysm (AAA) repair. The aim of the present study
was to compare results of endovascular and open aneurysm
repair (EVAR and OR) with adjusted standard populations,
including stratification for urgency of presentation.
Methods Retrospective analysis of prospectively col-
lected data of 401 consecutive patients presenting with
AAA between January 1998 and December 2002. Cross-
sectional follow up was 58 ± 29 months. Patients were
grouped into three cohorts: elective EVAR (n = 68),
elective OR (n = 244), and emergency OR (including
symptomatic and ruptured AAA, n = 89). Endpoints were
perioperative (i.e., 30 days or in-hospital) and late mor-
tality rates, as well as long-term QoL as assessed by the
Short Form health survey questionnaire (SF-36).
Results Mean age was lower in the elective OR cohort
(66 ± 10 years) than in the EVAR cohort (72 ± 7 years;
p \ .05). Perioperative mortality rates were 4.4%, 0.4%,
and 10.1%, for the EVAR, elective OR, and emergency OR
cohorts, respectively (p \ .05). Corresponding cumulative
survival rates after 4 years were 67%, 89%, and 69%,
respectively. Long-term QoL SF-36 scores were in all
cohorts similar to age- and gender-adjusted standard
populations, which score between 85 and 115: 99.6 ± 35.8
(EVAR), 101.3 ± 32.4 (elective OR), and 100.4 ± 36.5
(emergency OR).
Conclusions Long-term QoL is not permanently impaired
after AAA repair, but returns in long-term survivors to
what would be expected in a standard population. In this
respect, differences were found neither between EVAR and
OR, nor between elective and emergency repair. Periop-
erative mortality rates were highest in patients undergoing
emergency OR. The outlook for such patients after the
perioperative period, however, was similar to that for
patients undergoing elective repair.
Introduction
Repair of abdominal aortic aneurysms (AAA) can be
achieved by either open or endovascular aneurysm repair
(OR or EVAR). Both treatment modalities are well estab-
lished in terms of perioperative morbidity and mortality,
long-term survival, and cost-effectiveness [1–7], and both
feature distinct advantages and disadvantages. Specifically,
EVAR is less invasive than OR and is associated with sig-
nificantly lower operative mortality [8, 9]. However, its
long-term durability is still uncertain, and serious concerns
have been raised because long-term complications have
been reported in 25–40% of patients. Many of the patients
with such complications may need additional interventions
or—uncommonly—even conversion to open surgery during
follow-up. Moreover, the ultimate AAA complication—i.e.,
continuing aneurysm expansion and rupture—cannot be
prevented once and for all. Therefore, close surveillance of
EVAR patients over many years is still considered manda-
tory [5, 6, 10–14].
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Health related quality of life (QoL) is increasingly rec-
ognized as a critical parameter in the assessment of
outcome [15]. Although a faster return to normal QoL has
been ascribed to EVAR, long-term QoL was found to be
significantly higher after OR after the first 6 months [13].
The patient’s uncertainty about long-term durability of
EVAR, as made clear to the individual by close endograft
surveillance, might underlie this difference. Emergency
repair of ruptured AAA (rAAA) on the other hand, while
associated with relevant operative mortality, has been
reported to barely affect long-term QoL [16]. Such data are
essential to justify high attendant financial costs of AAA
repair [17, 18] and to determine resource allocation to
different treatment options [4].
The aim of this single-center series was to analyze long-
term survival as well as long-term QoL of surviving
patients after EVAR and OR, respectively, and to compare
them with an age- and gender-adjusted standard popula-
tion. Stratification for urgency of presentation (i.e., elective
versus emergency repair) was included.
Materials and methods
Post hoc analysis was carried out on a prospectively
registered, consecutive series of 401 patients who were
treated for AAA between January 1998 and December
2002 at our institution. Mean age of patients was
68 ± 9 years, and 349 patients were men (87%). Col-
lected information included pre-existent co-morbidities,
cardiovascular risk factors, aneurysm morphology, as well
as in-hospital morbidity, mortality, and length of stay
(Table 1). Identification of risk factors was based on
previously published definitions [19]. If percutaneous
Table 1 Demographic characteristics, preoperative data, and in-hospital outcome
EVAR Elective OAR Emergency OAR
Demographics
Number of patients 68 17.0% 244 60.8% 89 22.2%
Male gender 64 94.1% 203 83.2% 82 92.1%
Age, years 71.7 ± 7.2 66.4 ± 10.0* 70.6 ± 9.1
Preoperative data
Diameter, cm 5.9 ± 1.2 6.8 ± 1.4* 7.5 ± 1.8*
Diabetes 6 8.8% 35 14.3% 5 5.6%
Tobacco use 30 44.1% 94 38.5% 39 43.8%
Hypertension 37 54.4% 111 45.5% 52 58.4%
Hyperlipidemia 18 26.5% 79 32.4% 16 18.0%
Coronary artery disease 28 41.2% 74 30.3% 34 38.2%
History of MI 18 26.5% 56 23.0% 24 27.0%
PTCA 11 16.2% 19 7.8% 11 12.4%
CABG 6 8.8% 11 4.5% 3 3.4%
COPD 15 22.1% 18* 47.4% 22 24.7%
In-hospital outcome
Mortality 3 4.4% 1 0.4% 9* 10.1%
Bleeding 0 0.0% 6 2.5% 5 5.6%
Infection 2 2.9% 14 5.7% 5 5.6%
Limb ischemia 2 2.9% 8 3.3% 5 5.6%
Immediate conversion 1 1.5% 0 0.0% 0 0.0%
Length of stay
Intensive care, days 0.3 ± 0.3 0.8 ± 0.5 1.8 ± 2.1*
Overall, days 8.3 ± 7.6 10.2 ± 7.2* 14.8 ± 8.6*
In-hospital data for patients who underwent repair of abdominal aortic aneurysm (AAA) either by endovascular aortic repair (EVAR: n = 68),
elective open aortic repair (OR: n = 244); or emergency OR (i.e., symptomatic or ruptured AAA: n = 89). EVAR and elective OR patients were
postoperatively monitored on an intermediate care unit (2.3 ± 2.4 and 2.8 ± 1.2 days, respectively). Results are displayed as absolute values or
as mean values ± SD
M, myocardial infarction; PTCA, percutaneous transluminal coronary angioplasty; CABG, coronary artery bypass grafting; COPD, chronic
obstructive pulmonary disease
* p \ 0.05 comparing EVAR to OAR (elective or emergency)
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transluminal coronary angioplasty (PTCA) had recently
been performed, scheduled aortic repair was postponed
for 8–12 weeks. Approval of the local ethics committee
was obtained before outcome analysis.
Aortic abdominal aneurysms were treated (1) if they
presented with a maximum transverse infrarenal aortic
diameter of 50–55 mm or more, (2) if imaging evidence
documented AAA of 1.5 times the reference aortic diam-
eter with an expansion rate of [10% per year, or (3) if they
were symptomatic or had ruptured. During the study per-
iod, indications for EVAR were limited to patients over
65 years of age with a high surgical risk and with favorable
aneurysm morphology, i.e., a long infrarenal aortic neck
(i.e., longer than or equal to 20 mm without conical shape),
absence of mural thrombus at the level of the aortic neck,
an aortic neck angulation of less than 60 with respect to
the aneurysm axis, as well as non-tortuous and patent
pelvic axes on both sides. Additionally, at least one
hypogastric artery had to be deemed preservable. Appre-
ciation of urgency was based on history, presenting
symptoms, and computed tomographic angiographies,
which were obtained whenever patients were stable enough
preoperatively. Rupture of AAA was defined as loss of
continuity of the aortic wall in the region of aneurysm
associated with fresh blood outside the wall of the aneu-
rysm. In order to be classified in this way, rupture had to be
confirmed by intraoperative finding of a retroperitoneal
hematoma or suffusion and a rupture site in the aneurysm.
All other patients with clinical suspicion of rupture or
exquisitely painful aneurysms on direct palpation were
considered symptomatic, but still urgent. Individual deci-
sions regarding treatment of AAA were left to the
discretion of the attending surgeon with consideration of
patient request.
All patients were followed systematically after aortic
repair in a specialized outpatient clinic: after OR, patients
were seen after 3 months, and annually to every second
year thereafter for an abdominal duplex sonography check.
After EVAR, patients returned after 3, 6, 12, 18, and
24 months and annually thereafter as proposed by the
EUROSTAR protocol [12]. Additionally, from October
2000 on, all eligible EVAR patients were included in the
EUROSTAR registry.
For cross-sectional assessment of present-day QoL, all
surviving patients were contacted between January and
June 2006 by means of the validated German version of the
self-administered Short Form health survey questionnaire
(SF-36). The questionnaire was sent a second time to non-
responders before they were contacted by phone. Mean
follow-up constituted 58 ± 29 months. Outcome was
analyzed according type of aortic repair, i.e., elective OR,
emergency OR, and EVAR.
Study endpoints
Perioperative mortality and morbidity included all events
within 30 days of treatment or when the patient was still in
the hospital. Collected events included surgical site infec-
tions and severe bleeds, as well as occurrence of acute lower
limb ischemia, and were registered if they prompted surgical
revision during the same hospital stay. Cumulative long-
term survival was assessed according to the method proposed
by Kaplan and Meier [20]. Quality of life was assessed with
the self-administered SF-36 questionnaire [21–23]. Details
of this validated questionnaire have been published previ-
ously [24]. Briefly, the SF-36 consists of 36 short questions
reflecting QoL in eight different aspects: bodily pain
(abbreviated BP, two items); mental health (MH, five items);
vitality (VT, four items); social functioning (SF, two items);
general health (GH, five items); physical functioning (PF, 10
items); and role functioning, both emotional (RE, three
items) and physical (RP, four items). Role functioning
reflects the impact of emotional and physical disability on
work and regular activity (the individual’s normal everyday
role). Raw points generate a score for each dimension, which
add up to a total raw score ranging from 0 to 100, with 100
reflecting best functioning. Raw scores then were adjusted
for age and gender by multiplication with the appropriate
factor based on a validated Western European standard
population (Sweden, n = 8,930) according to the SF-36
manual [22, 23], thereby generating an adjusted score.
Normal values for the adjusted score range from 85 to 115.
Statistical analysis
Continuous variables are summarized as mean (±one
standard deviation [SD]), when normally distributed, and
as median (range), when asymmetrically distributed. Cat-
egorical variables are presented as numbers (percentages).
Differences between continuous variables were compared
by two-tailed unpaired t-test if normally distributed, and by
the Mann–Whitney U-test, if asymmetrically distributed.
Categorical variables were compared by two-tailed Fish-
er’s exact test. Kaplan–Meier survival estimates were
correlated by v2 testing with estimated actual mortality
risks of the age-adjusted Swiss population as published by
the Swiss Federal Statistical Office (http://www.bfs.
admin.ch/bfs/portal/en/index.html). SF-36 scores were
analyzed in accordance with the SF-36 manual, replacing
missing values using the described algorithm [22, 23].
After adjustment for age and gender, SF-36 scores were
compared by means of Mann-Whitney U-test. Results were
stratified for modality of treatment and urgency of pre-
sentation. A p-value of less than 0.05 was considered
to indicate statistical significance. All analyses were
World J Surg (2008) 32:987–994 989
123
performed using a computerized software package, SPSS
for Windows, version 15.0.
Results
Of the 401 patients with AAA, 244 underwent elective OR
(60.1%), 89 were treated by emergency OR (22.2%), and
68 patients received elective EVAR (17.0%). Of the urgent
patients, 51 presented with rAAA (57.3%). Differences
between treatment cohorts regarding demographic and
preoperative characteristics, as well as in-hospital outcome
are given in Table 1. Patients treated by elective OR were
significantly younger than EVAR patients (66 ± 10 years
versus 72 ± 7 years; p \ 0.05). The EVAR patients,
however, presented with significantly smaller AAA-diam-
eters than patients treated by either elective or emergency
OR (p \ 0.05). Distribution of cardiovascular risk factors
was similar in all treatment cohorts (p = ns). However,
history of previous myocardial infarction, PTCA and cor-
onary artery bypass graft (CABG)-surgery, as well as
presence of chronic obstructive pulmonary disease
(COPD), were both significantly more prevalent in patients
who underwent EVAR. One of the elective OR patients had
had EVAR prior to actual aortic repair.
Thirteen patients died while still in hospital, giving an
overall perioperative mortality rate of 3.2%. Stratified rates
were 4.4, 0.4, and 10.1% for the EVAR, elective OR, and
emergency OR cohorts, respectively (p \ 0.05). Length of
hospital stay was significantly longer in patients who
underwent emergency OR (14.8 ± 8.6 days), as compared
to elective OR or EVAR (10.2 ± 7.2 and 8.3 ± 7.6 days,
respectively; p \ 0.05). Of 388 discharged patients, 61
died during follow-up (15.7%; Table 2), accounting for
cumulative survival estimates of 86 (EVAR), 97 (elective
OR), and 85% (emergency OR) at 1 year, and 67, 89, and
69% at 4 years, respectively (Fig. 1). Based on the sample
size of the cohorts, no statistically significant differences
were found when compared to the expected 4-year survival
rate of the Swiss population, which actually is estimated to
be around 90% for 66-year-olds, and around 85% for 71-
year-olds.
All survivors (n = 327) could be contacted for follow-up
(100%). Forty-three patients, however, did not answer the
questionnaire, either due to language problems, medical
reasons (end-stage tumor, cerebrovascular incident, n = 6),
or refusal. However, all non-responders were contacted by
phone and all were alive. Overall return rate of question-
naires among surviving patients therefore was 86.8%.
Long-term QoL (measured after 58 ± 29 months) was
good in all treatment cohorts, with an average SF-36 score of
99.6 ± 35.8 in the EVAR cohort, 101.2 ± 35.2 in the
elective OR cohort, and 100.4 ± 36.5 in the emergency OR
cohort. These results are similar to data obtained in an age-
Table 2 Perioperative and long-term mortality
EVAR Elective OAR Emergency OAR
Early (30 day)
Patients n (%) 68 17.0% 244 60.8% 89 22.2%
Perioperative mortality n (%) 3 4.4% 1 0.4% 9 10.1%
Follow-up
Average, years 4.6 ± 1.9 4.9 ± 2.5 4.8 ± 2.0
Crude mortality n (%) 19 27.9% 22 9.0% 20 22.5%
Follow-up data for patients who underwent repair of AAA either by EVAR (n = 68), OR (n = 244); or emergency OR (i.e., symptomatic or
ruptured AAA: n = 89). Perioperative mortality includes all deaths occurring within first 30 days after procedure, and of all patients contin-
uously hospitalized until death
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Fig. 1 Cumulative survival rates after abdominal aortic aneurysm
(AAA) repair as assessed by the Kaplan-Meier method and stratified
for treatment cohorts. EVAR endovascular aneurysm repair; OR open
aneurysm repair. Emergency OR included repair of symptomatic and
ruptured AAA
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and gender-matched standard population, which scores
between 85 and 115. Separate analysis of individual phys-
ical and psychological domains showed the same results: All
three cohorts scored within normal range in both physical
and mental domains, after adjustment for age and gender.
Particularly in the key dimension mental health, all cohorts
scored in the same range, rendering the cohorts actually
comparable for all other domains of the SF-36.
Discussion
Being the thirteenth leading cause of death in the United
States, AAA is an important and costly health concern.
Although OR basically has prevailed since its introduction
on 29 March 1951 [25], it still carries substantial morbidity
and mortality. The most important reasons are the exten-
sive operative trauma, the changes in renal blood flow
induced by aortic clamping, the blood loss, and the ische-
mia–reperfusion injury to the lower part of the body and
the intestines. Hence, OR is currently being challenged by
minimally invasive techniques (EVAR) as the treatment of
choice for AAA. Elective operative mortality and mor-
bidity have been established quite congruently for both
modalities, with reported results depending on the respec-
tive study design. Accepted 30-day mortality rates range
around 3.8% for elective OR [7], and around 1.5% for
elective EVAR [8, 9]. However, EVAR offered no mid-
term advantage over OR with respect to all-cause mortality
and QoL in a randomized controlled trial (RCT) [5], but it
was more expensive and led to a greater number of com-
plications and additional interventions. Thus, the long-term
efficacy and durability of EVAR remains uncertain, since
its perioperative advantages might be lost after the first
postoperative year [6]. Reports on corresponding rates for
emergency repair of AAA are less congruent, in part
because discrimination between symptomatic and rAAA is
not consistently reported, and in part because overall
mortality versus in-hospital mortality cannot always be
differentiated. Reported results therefore range from 15%
to 90% but are usually quoted approximately as 40–45%
for emergency OR [17, 26].
Assessing the outcome of surgery simply by crude
morbidity and mortality rates fails to take into account the
patient’s perspective. Quality of Life essentially subsumes
the relative importance of all intervention-related sequelae
to the results noted by the patient, and its assessment has
therefore become increasingly important in many fields of
medicine; likewise in vascular surgery [15]. A number of
studies have assessed postoperative QoL after elective or
emergency AAA repair [4, 16, 27–32], and some have even
compared QoL after OR and EVAR in a RCT design
[5, 13]. As expected, patients treated by EVAR invariably
returned earlier than OR patients to preoperative QoL.
Surprisingly, however, OR patients had a significantly
better QoL than EVAR patients from 6 months on in one
RCT [13]. Contrary to common suggestions in the litera-
ture [29, 30], the authors of the DREAM trial did not
ascribe this relative QoL impairment to a close surveillance
program after EVAR, because both study arms were
monitored equally. They rather suggested that knowledge
of having definitely survived a severe illness and major
surgery plays a critical role. In line with that conclusion,
long-term QoL after emergency OR has been found to be
equal to elective OR, as well as to age- and gender-adjusted
controls [4, 16]. However, in another series the radical
change experienced by patients who underwent an emer-
gency OR was followed by deterioration in QoL, whereas
those who had elective OR reported improved QoL, which
relativizes this notion [27].
In our series 401 consecutive patients with large or
symptomatic AAA were included over a period of 5 years.
The study population therefore reflects the real life spec-
trum of AAA pathology in a tertiary referral center. There
was no loss to follow up. For cross-sectional QoL assess-
ment among survivors, a validated tool was used (SF-36)
with a representative return rate (86.8%). Most of the other
mentioned studies concentrating on QoL after AAA repair
were found to investigate either small or selected samples,
to be retrospective with incomplete follow-up, or not to
have used validated QoL assessment tools in a systematic
review [4]. The QoL assessment instruments used, as
described in this review were heterogeneous and ranged
from non-validated, disease-specific, and self-designed
questionnaires to generic and complex multidimensional
interrogation tools. Direct comparisons of results may
therefore be extremely delicate. The main advantage of the
SF-36 QoL questionnaire as used in the present study is its
reliable validation and broad acceptance. The generic
design renders it widely applicable, and its methodology
has been used successfully for vascular patients before by
our group [24, 33] and others [4, 15]. Intriguingly, statis-
tical adjustments for age and gender allow comparisons
with standardized Western European control populations
[22, 23]. SF-36 thereby presumably conveys a reasonable
notion of the range a normal QoL could be expected to be
for the respective demographic segment.
The main finding of our study was that long-term QoL
returned to a normal range independent of treatment
modality or urgency. Hence, QoL was equal to age- and
gender-matched healthy subjects 4–5 years after aortic
repair in all treatment cohorts. This is in line with was has
been found in a recent systematic review for emergency
AAA repair, although all included studies had smaller
sample sizes than our emergency OR cohort [4]. For
elective AAA repair, however, our series did not reproduce
World J Surg (2008) 32:987–994 991
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the findings of the DREAM trial, where OR patients had a
relatively better postoperative QoL in the long term than
EVAR patients [13]. Indeed, no statistically significant
differences were found between elective OR and EVAR
patients regarding long-term QoL in our series. As all
treatment cohorts returned to the same QoL as their healthy
peers, the interpretation that aneurysm repair did not
deteriorate QoL in these risk populations is probably jus-
tified and seems to be particularly true for EVAR patients,
who represented the least favorable patient selection. The
study thereby certainly corroborates the findings of the
EVAR 1 trial in this respect [5]. However, it must be borne
in mind that only long-term survivors were assessed, and
they could be suspected to represent favorable selection,
not only with respect to co-morbidities but also to QoL.
In comparison to the literature, mortality rates were very
low in the OR cohorts. In particular, emergency OR
patients had a perioperative mortality rate (10.1%) that lies
well beneath commonly published rates (15–90%) [17].
The First Vascunet Database Report 2007 of the European
Society for Vascular Surgery (ESVS) describes outcome of
over 33,000 AAA patients in six Western countries [26]. In
these pooled data, operative mortality in the corresponding
age group was around 35% for emergency OR. The oper-
ative mortality for symptomatic AAA alone—i.e.,
excluding rAAA—was still 9.6%. Therefore the assump-
tion that our low operative mortality figure for emergency
OR was simply based on the inclusion of symptomatic
patients does not seem justified. A possible explanation for
this favorable figure, however, is an extremely well-
rehearsed team approach to symptomatic or rAAA.
Therefore, the concept of permissive hypotension with
hypotensive hemostasis, as propagated by Crawford and
others since the early 1990s [34], was integrated into our
rescue chain and includes paramedics, anesthesiologists,
and vascular surgeons, who detain fluid resuscitation
whenever possible until surgical control of hemorrhage has
been reached.
Other important factors include preoperative imaging
whenever possible, induction of general anesthesia and
intubation only in the operating theatre, with the surgeon
ready to cut, and the presence of at least two vascular
surgeons supported by one or two assistants at such oper-
ations. A dense health care system in Switzerland, with
short rescue paths and concentration of demanding vascu-
lar surgery in dedicated specialized centers further
facilitates low operative mortality figures.
The fraction of emergency AAA (22%)—and even more
of rAAA (13%)—is comparatively low in the presented
material. Similar figures were found for the whole country in
the First Vascunet Database Report 2007, where Switzerland
had the lowest rate of emergency AAA repair (\20%) as
compared for instance to Denmark where this rate
approached 50% (37% for rAAA). It is unclear whether this
difference is due to reporting bias or whether it reflects an
improved aneurysm screening and surveillance program.
During the study period, ten patients with rAAA were not
operated on because of ongoing mechanical reanimation at
admission. Unfortunately, we have no information on how
many patients with rAAA were actually not referred to us or
who died on the way during the same period of time.
With a similar team approach, operative mortality of
elective OR can be kept comparably low in dedicated
centers. In the present series, the figure was well below 1%,
whereas the Vascunet Database [26] reported an average
mortality ten times higher for the same age group, i.e.,
around 5%. The favorable impact of experience in patient
management and high surgical volume has been endorsed
in a recent survey of 131 German hospitals [35]. Operative
mortality of elective EVAR, however, was somewhat ele-
vated in the present series (4.4%) when compared to recent
literature, where figures around 2% are typically reported
[8, 26]. Several reasons may account for this finding. Our
patient selection for EVAR shows a high prevalence of
relevant cardiopulmonary co-morbidities (Table 1), which
reflects the policy of our department at the time to mainly
treat AAA patients with high surgical risk with EVAR.
Furthermore, only patients of advanced age were offered
EVAR. Another important factor may be that EVAR was
not employed on a regular basis in our department until
1997. Therefore part of the learning curve might be
incorporated into the analysis. Finally, improvements in
device design since the end of the present study have led to
drastic improvements in reported outcome.
Long-term survival after the perioperative period was
similar to the expected survival of the age-matched Swiss
population as estimated by the Swiss Federal Statistical
Office for all treatment cohorts. However, whereas both
OR cohorts displayed a fairly parallel trend of survival
curves over 4 years, survival after EVAR fell to a some-
what steeper degree. Although, because of the small
sample size, no statistically significant difference was
found in comparison to a normal survival curve, the dif-
ference in survival after the different procedures probably
reflects selection of patients with significant disease.
Limitations of study
Several limitations of this cross-sectional outcome analysis
of prospectively collected treatment cohorts have to be
addressed. Mean follow-up was almost 5 years, and it
included a considerable variance, as expected of a study
period of 5 years. Additionally, because this was a non-
randomized, observational series, basic requirements for
comparability of treatment cohorts were not met (Table 1).
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Statistical control of results was sought by z-testing against
the norms of standard populations. With regard to life
expectancy, estimated Swiss norms could be used. As for
QoL assessment, unfortunately no validated ‘‘Swiss norm’’
exists. The large Swedish series (n = 8,930) used for QoL
comparison is a validated SF-36 reference population of
people from similar socioeconomic backgrounds. There-
fore a comparable QoL can probably safely be assumed.
Furthermore, an ideal QoL assessment tool should be
independent of geographic, linguistic, or cultural bound-
aries [15]. The SF-36—although certainly not meeting all
criteria of the ideal—is a generic QoL instrument with a
high degree of validation and acceptance. It thus has been
recommended for use in vascular disease-related QoL
assessments and outcome analyses, particularly because of
its validated translations into many major languages, which
make it a truly international scale of health-related QoL
[15]. However, it certainly has its limitations, mainly
affecting its sensitivity regarding bodily pain and func-
tional impairments. Additionally, floor effects in role
functioning have been described in very ill patients, where
the test loses some of its discriminatory force for deterio-
ration [15]. Combining it with disease-specific QoL
instruments would certainly be desirable to compensate for
some of these limitations. However, existing tools specific
for vascular diseases, such as the VascuQoL, Walking
Impairment Questionnaire, or PAD Questionnaire, all
concentrate on peripheral arterial occlusive disease and
therefore do not serve our purpose [36]. To our knowledge,
at the time of this study, there was no validated QoL
assessment tool specific for AAA patients.
As discussed above, a limitation of the cross-sectional
QoL assessment is the lack of longitudinal information.
Hence patients with favorable outcome may have been
selected by this process, as no QoL information on patients
who died during follow-up was available. Results therefore
represent QoL of long-term survivors rather than QoL
outcome of all originally treated patients. However, from
the patients’ perspective, the information that normal long-
term QoL can be expected in survivors may be comforting.
Whether the favorable long-term QoL in surviving patients
is due solely to ‘‘natural selection’’ or whether, to a degree,
it represents a limitation of SF-36 design is hard to
determine.
Although the return rate of SF-36 questionnaires mailed
to our patients was representative in all cohorts ([80%),
the missing information was probably not random.
Whereas very few patients did not answer because of
severe illness (n = 6), language problems accounted for
the majority of the deficit. The primary language of the
majority of our patients is German. We therefore used the
validated German version of the SF-36. Hence the majority
of missing questionnaires was due to the inability of many
Italian- or French-speaking patients to answer such a
questionnaire in a foreign language. However, we have
previously shown that patient characteristics basically are
not different between the different linguistic parts of
Switzerland [24].
In conclusion, long-term QoL is not permanently
impaired after AAA repair. In long-term survivors it
returns to what would be expected in an age- and gender-
adjusted standard population in all eight aspects assessed
by the SF-36. In this respect, no differences could be found
either between EVAR and OR or between elective and
emergency repair. Perioperative mortality rates were
highest in patients undergoing emergency OR. Their out-
look after the perioperative period, however, is similar to
that for patients undergoing elective repair.
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